BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 23418553)

  • 1. Associations between methylation of paternally expressed gene 3 (PEG3), cervical intraepithelial neoplasia and invasive cervical cancer.
    Nye MD; Hoyo C; Huang Z; Vidal AC; Wang F; Overcash F; Smith JS; Vasquez B; Hernandez B; Swai B; Oneko O; Mlay P; Obure J; Gammon MD; Bartlett JA; Murphy SK
    PLoS One; 2013; 8(2):e56325. PubMed ID: 23418553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer.
    Vidal AC; Henry NM; Murphy SK; Oneko O; Nye M; Bartlett JA; Overcash F; Huang Z; Wang F; Mlay P; Obure J; Smith J; Vasquez B; Swai B; Hernandez B; Hoyo C
    Clin Transl Oncol; 2014 Mar; 16(3):266-72. PubMed ID: 23775149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia.
    Piyathilake CJ; Macaluso M; Alvarez RD; Chen M; Badiga S; Edberg JC; Partridge EE; Johanning GL
    Cancer; 2011 Mar; 117(5):957-63. PubMed ID: 20945322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted, Deep Sequencing Reveals Full Methylation Profiles of Multiple HPV Types and Potential Biomarkers for Cervical Cancer Progression.
    Liu P; Iden M; Fye S; Huang YW; Hopp E; Chu C; Lu Y; Rader JS
    Cancer Epidemiol Biomarkers Prev; 2017 Apr; 26(4):642-650. PubMed ID: 28069683
    [No Abstract]   [Full Text] [Related]  

  • 5. Detection of hypermethylated genes in women with and without cervical neoplasia.
    Feng Q; Balasubramanian A; Hawes SE; Toure P; Sow PS; Dem A; Dembele B; Critchlow CW; Xi L; Lu H; McIntosh MW; Young AM; Kiviat NB
    J Natl Cancer Inst; 2005 Feb; 97(4):273-82. PubMed ID: 15713962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
    Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
    Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status.
    Hublarova P; Hrstka R; Rotterova P; Rotter L; Coupkova M; Badal V; Nenutil R; Vojtesek B
    Int J Gynecol Cancer; 2009 Apr; 19(3):321-5. PubMed ID: 19407553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.
    Kremer WW; van Zummeren M; Heideman DAM; Lissenberg-Witte BI; Snijders PJF; Steenbergen RDM; Dreyer G; Meijer CJLM
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30360578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV-type distribution and reproducibility of histological diagnosis in cervical neoplasia in Poland.
    Nowakowski A; de Souza SC; Jach R; Rosillon D; Książek A; Holl K
    Pathol Oncol Res; 2015 Jul; 21(3):703-11. PubMed ID: 25547828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of
    Holubekova V; Mersakova S; Grendar M; Snahnicanova Z; Kudela E; Kalman M; Lasabova Z; Danko J; Zubor P
    Genet Test Mol Biomarkers; 2020 May; 24(5):256-263. PubMed ID: 32311274
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between PEG3 DNA methylation and high-grade cervical intraepithelial neoplasia.
    Bosire C; Vidal AC; Smith JS; Jima D; Huang Z; Skaar D; Valea F; Bentley R; Gradison M; Yarnall KSH; Ford A; Overcash F; Murphy SK; Hoyo C
    Infect Agent Cancer; 2021 Jun; 16(1):42. PubMed ID: 34120615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
    Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
    Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.
    Gillio-Tos A; Bicalho Mda G; Fiano V; Grasso C; Tarallo V; De Marco L; Trevisan M; Xavier M; Slowik R; Carvalho NS; Maestri CA; Lacerda HM; Zugna D; Richiardi L; Merletti F
    BMC Cancer; 2012 Dec; 12():618. PubMed ID: 23265140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.
    De Strooper LMA; Berkhof J; Steenbergen RDM; Lissenberg-Witte BI; Snijders PJF; Meijer CJLM; Heideman DAM
    Int J Cancer; 2018 Sep; 143(6):1541-1548. PubMed ID: 29663363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the CDH1, TIMP3, and MGMT genes.
    Teixeira da Costa Lodi C; Michelin MA; Miranda Lima MI; Murta EFC; Braga LDC; Montes L; Melo VH
    Arch Gynecol Obstet; 2018 Nov; 298(5):971-979. PubMed ID: 30218185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
    Luttmer R; De Strooper LM; Berkhof J; Snijders PJ; Dijkstra MG; Uijterwaal MH; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; Van Baal WM; Graziosi PG; Quint WG; Heideman DA; Meijer CJ
    Int J Cancer; 2016 Feb; 138(4):992-1002. PubMed ID: 26317579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
    Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
    Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burning wood in the kitchen increases the risk of cervical neoplasia in HPV-infected women in Honduras.
    Velema JP; Ferrera A; Figueroa M; Bulnes R; Toro LA; de Barahona O; Claros JM; Melchers WJ
    Int J Cancer; 2002 Feb; 97(4):536-41. PubMed ID: 11802219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.